Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EPS (Basic) (2020 - 2025)

Cellebrite DI's EPS (Basic) history spans 6 years, with the latest figure at $0.09 for Q4 2025.

  • Quarterly EPS (Basic) fell 4.35% to $0.09 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $462532.3 through Dec 2025, up 219.85% year-over-year, with the annual reading at $0.32 for FY2025, 123.7% up from the prior year.
  • EPS (Basic) came in at $0.09 for Q4 2025, down from $84120.8 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $259866.7 in Q2 2021 to a low of -$198255.6 in Q1 2024.
  • The 5-year median for EPS (Basic) is $1612.2 (2021), against an average of $31673.0.
  • Year-over-year, EPS (Basic) surged 5829.45% in 2022 and then tumbled 298.82% in 2023.
  • Cellebrite DI's EPS (Basic) stood at $0.36 in 2021, then tumbled by 89.24% to $0.04 in 2022, then crashed by 298.82% to -$0.08 in 2023, then skyrocketed by 219.42% to $0.09 in 2024, then fell by 4.35% to $0.09 in 2025.
  • Per Business Quant, the three most recent readings for CLBT's EPS (Basic) are $0.09 (Q4 2025), $84120.8 (Q3 2025), and $129840.0 (Q2 2025).